J&J Taps Gorsky To Be Its Next CEO
This article was originally published in The Pink Sheet Daily
Alex Gorsky was one of two internal candidates who had been vying for the position, which will become available as William Weldon yields the position on April 26.
You may also be interested in...
As Sanofi looks for a replacement for Chris Viehbacher, it might want to take the recent track records of the CEOs at its competitors into consideration before making a decision.
In a conversation shortly before taking the helm at Johnson & Johnson, CEO Gorsky discusses deal strategies, emerging markets, his experience on both the device and pharma sides of the business, and opportunities for drug/device convergence.
The reorganization separates the U.S. OTC business - McNeil Consumer Healthcare - from the other consumer divisions "in order to give focused attention to quality and compliance, and the critical task of restoring" McNeil brands.